Arnauld VERSCHUUR
CHU La Timone
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Arnauld VERSCHUUR as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:45 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT05384821 · Metronomic Chemotherapy in Wilms Tumor (MetroWilms-1906)Centre Oscar Lambret · recruiting · Wilms Tumor · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:45 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:45 UTC. The ranking covers the 200 most relevant of 13 PubMed records, and a shared surname and initials can bring in a namesake. All 13 on PubMed
- Pilot study of a pediatric metronomic 4-drug regimen.Oncotarget · 201158 citationsRCR 1.6
- 47 citationsRCR 1.4
- Stromal and epithelial predominant Wilms tumours have an excellent outcome: the SIOP 93 01 experience.Pediatr Blood Cancer · 201044 citationsRCR 1.2
- Cobimetinib in Pediatric and Young Adult Patients with Relapsed or Refractory Solid Tumors (iMATRIX-cobi): A Multicenter, Phase I/II Study.Target Oncol · 202243 citationsRCR 3.2
- 36 citationsRCR 1.0
- Outcome of patients with stage IV high-risk Wilms tumour treated according to the SIOP2001 protocol: A report of the SIOP Renal Tumour Study Group.Eur J Cancer · 202032 citationsRCR 2.0
- Regorafenib plus Vincristine and Irinotecan in Pediatric Patients with Recurrent/Refractory Solid Tumors: An Innovative Therapy for Children with Cancer Study.Clin Cancer Res · 202330 citationsRCR 2.8
- Sunitinib in pediatric patients with advanced gastrointestinal stromal tumor: results from a phase I/II trial.Cancer Chemother Pharmacol · 201928 citationsRCR 1.0
- Phase II study of temozolomide and topotecan (TOTEM) in children with relapsed or refractory extracranial and central nervous system tumors including medulloblastoma with post hoc Bayesian analysis: A European ITCC study.Pediatr Blood Cancer · 202021 citationsRCR 1.0
- [Prevention of sickle cell crises with multiple phlebotomies].Arch Pediatr · 200018 citationsRCR 0.4